Takaomi Sanda

Takaomi Sanda

UNVERIFIED PROFILE

Are you Takaomi Sanda?   Register this Author

Register author
Takaomi Sanda

Takaomi Sanda

Publications by authors named "Takaomi Sanda"

Are you Takaomi Sanda?   Register this Author

59Publications

1958Reads

44Profile Views

Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment.

Cancers (Basel) 2020 Jan 15;12(1). Epub 2020 Jan 15.

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600 Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12010211DOI Listing
January 2020

[Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].

Authors:
Takaomi Sanda

Rinsho Ketsueki 2018;59(7):899-908

Cancer Science Institute of Singapore, National University of Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.59.899DOI Listing
July 2019

Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.

Int J Hematol 2019 Jan 25;109(1):5-17. Epub 2018 Aug 25.

Cancer Science Institute of Singapore, National University of Singapore, Centre for Translational Medicine, 14 Medical Drive, #12-01, Singapore, 117599, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-018-2518-zDOI Listing
January 2019

Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.

Leukemia 2018 10 26;32(10):2138-2151. Epub 2018 Mar 26.

Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0110-4DOI Listing
October 2018

Targeting General Transcriptional Machinery as a Therapeutic Strategy for Adult T-Cell Leukemia.

Molecules 2018 May 2;23(5). Epub 2018 May 2.

Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules23051057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099935PMC
May 2018

RUNX1 in T-ALL: tumor suppressive or oncogenic?

Authors:
Takaomi Sanda

Blood 2017 10;130(15):1686-1688

NATIONAL UNIVERSITY OF SINGAPORE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-802181DOI Listing
October 2017

Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.

Adv Exp Med Biol 2017 ;962:139-147

Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-981-10-3233-2_10
Publisher Site
http://dx.doi.org/10.1007/978-981-10-3233-2_10DOI Listing
September 2017

TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.

Exp Hematol 2017 09 24;53:7-15. Epub 2017 Jun 24.

Cancer Science Institute of Singapore, National University of Singapore, Singapore.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X173023
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2017.06.001DOI Listing
September 2017

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia.

Front Oncol 2017 25;7:218. Epub 2017 Sep 25.

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2017.00218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627022PMC
September 2017

Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Science 2014 Dec 13;346(6215):1373-7. Epub 2014 Nov 13.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Division of Pediatric Hematology-Oncology, Boston Children's Hospital, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1259037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720521PMC
December 2014

Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.

Gastroenterology 2014 Oct 3;147(4):882-892.e8. Epub 2014 Jul 3.

Departament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.06.041DOI Listing
October 2014

RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells.

Gene 2014 Jul 2;545(1):111-6. Epub 2014 May 2.

Cancer Science Institute of Singapore, National University of Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2014.04.074DOI Listing
July 2014

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.

Nature 2014 Jul 22;511(7511):616-20. Epub 2014 Jun 22.

1] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13393DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244910PMC
July 2014

Discovery of a selective irreversible BMX inhibitor for prostate cancer.

ACS Chem Biol 2013 Jul 26;8(7):1423-8. Epub 2013 Apr 26.

High Magnetic Field laboratory, Chinese Academy of Sciences , P.O. Box 1110, Hefei, Anhui 230031, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/cb4000629DOI Listing
July 2013

PIDD death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling.

Mol Cell 2012 Sep 30;47(5):681-93. Epub 2012 Jul 30.

Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2012.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444620PMC
September 2012

Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL.

J Exp Med 2011 Apr 4;208(4):663-75. Epub 2011 Apr 4.

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20102384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135352PMC
April 2011

ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.

J Exp Med 2010 Jul 21;207(7):1369-80. Epub 2010 Jun 21.

Howard Hughes Medical Institute, Children's Hospital, Immune Disease Institute, and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.jem.org/lookup/doi/10.1084/jem.20100285
Publisher Site
http://dx.doi.org/10.1084/jem.20100285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901073PMC
July 2010

Transcription factors as therapeutic targets in lymphoid malignancies.

Authors:
Takaomi Sanda

Int Rev Immunol 2007 Sep-Dec;26(5-6):305-32

Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08830180701655945DOI Listing
February 2008

Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.

Biochem Biophys Res Commun 2007 Sep 25;361(3):580-5. Epub 2007 Jul 25.

Department of Virology III, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0701489
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2007.07.035DOI Listing
September 2007

NF-kappa B signaling and carcinogenesis.

Curr Pharm Des 2007 ;13(5):447-62

Department of Molecular and Cellular Biology, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161207780162944DOI Listing
April 2007

Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid.

Haematologica 2007 Jan;92(1):115-20

Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.10300DOI Listing
January 2007

[Aberrant signal transductions in leukemia cell].

Nihon Rinsho 2007 Jan;65 Suppl 1:118-23

Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences.

View Article

Download full-text PDF

Source
January 2007

Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor.

Clin Cancer Res 2005 Mar;11(5):1974-82

Department of Molecular and Cellular Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-08601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1936DOI Listing
March 2005

RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator.

Eur J Biochem 2004 Sep;271(18):3741-51

Department of Molecular and Cellular Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1432-1033.2004.04314.xDOI Listing
September 2004

Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.

Int J Hematol 2002 Feb;75(2):195-200

Second Department of Internal Medicine, Nagoya City University Medical School, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf02982028DOI Listing
February 2002